Loading Events

« All Events

Virtual Event

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

February 9 @ 11:00 am - 3:00 pm EST

Virtual Event

The National Academies’ Forum on Drug Discovery, Development, and Translation will host a virtual public workshop on Feb 9, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally.

This virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years, since the previous workshop, Envisioning a Transformed Clinical Trials Enterprise in the United States, and, looking forward, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient, effective, person-centered, inclusive, and integrated into the health delivery system of 2030.

The event will consider achievable goals to enhance person-centeredness and inclusivity in the clinical trials enterprise; and discuss ways to improve public engagement and partnership.

Background

Clinical trials research has changed dramatically over the last decade. The biological, physical, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities, such as digital health technologies and artificial intelligence applications, are changing possibilities for the conduct of clinical research.

A planning committee of the National Academies of Sciences, Engineering, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030, featuring invited presentations and discussions on:

  • Lessons learned from progress and setbacks over the past 10 years.
  • How an envisioned 2030 clinical trials enterprise might differ from the current system.
  • Key priority challenges and opportunities when it comes to the 2030 clinical trials enterprise.
  • The following core themes in framing a 2030 agenda:
  • Diversity and inclusion of clinical trial participants
  • Convergence of clinical research and clinical practice
  • Clinical trial data sharing
  • Incorporation of new technologies into drug research and development
  • Workforce and career development
  • Public engagement and partnership
  • Regulatory Environment
  • Cultural and Financial Incentives
  • Practical short- and long-term goals for improving the efficiency, effectiveness, person-centeredness, inclusivity, and integration with healthcare of the clinical trials enterprise.

For additional information on the workshop series, please visit the project page.

Details

Date:
February 9
Time:
11:00 am - 3:00 pm EST
Event Categories:
,
Website:
https://bit.ly/nasem-clinicaltrialenterprise
Watch

Organizer

National Academies of Sciences, Engineering, and Medicine
Website:
http://www.nationalacademies.org/

Back to Top